Intercellular adhesion molecule-1 expression on the hepatocyte membrane of patients with chronic hepatitis B and C
1Third Department of Internal Medicine, Ehime University School of Medicine, Japan.
Insights
Intercellular adhesion molecule-1 (ICAM-1) expression on liver cells correlates with liver damage severity in chronic hepatitis B and C. ICAM-1 may be involved in T-cell-mediated liver injury.
Area of Science:
- Hepatology
- Immunology
- Virology
Background:
- Chronic hepatitis B (CHB) and C (CHC) are significant causes of liver disease.
- Hepatocellular injury in CHB and CHC involves immune responses.
- The role of cell adhesion molecules in hepatitis pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate the expression of intercellular adhesion molecule-1 (ICAM-1) on hepatocytes in patients with CHB and CHC.
- To determine the relationship between ICAM-1 expression and liver damage, viral markers, and immune cell infiltration.
Main Methods:
- Immunostaining of liver biopsies from 27 patients with CHB/CHC using a monoclonal antibody against ICAM-1.
- Assessment of ICAM-1 expression patterns and correlation with alanine aminotransferase (ALT) levels, histological grade, and presence of cytotoxic T cells (CD8+, CD11b-).
- Evaluation of ICAM-1 expression changes after interferon-alpha therapy in a subset of CHB patients.
Main Results:
- ICAM-1 was focally expressed in a honeycomb pattern on hepatocytes in 26/27 patients.
- ICAM-1 expression correlated significantly with ALT levels and histological liver damage grade.
- Abundant cytotoxic T cells were found in ICAM-1-positive areas, with co-localization in zones of focal necrosis.
- ICAM-1 expression decreased in some CHB patients after interferon-alpha therapy.
- No correlation was found between ICAM-1 expression and viral replication markers (DNA polymerase, HBcAg).
Conclusions:
- Hepatocyte ICAM-1 expression is a common feature in CHB and CHC.
- ICAM-1 expression is linked to the severity of liver damage and T-cell infiltration.
- ICAM-1 may play a crucial role in mediating hepatocellular injury through cytotoxic T cells in chronic viral hepatitis.
Abstract:
The expression of intercellular adhesion molecule-1 (ICAM-1) on the hepatocyte membrane was studied in 27 patients with chronic hepatitis B and C (CHB, CHC) by immunostaining using a monoclonal antibody. ICAM-1 was expressed focally in a honeycomb-like pattern by hepatocytes in livers of 26/27 patients. The degree of ICAM-1 expression was closely related to the ALT level and the histological grade of liver damage. Abundant cytotoxic T cells (CD8+, CD11b-) were found in ICAM-1-positive areas of the liver. Zones of focal necrosis contained both ICAM-1-positive hepatocytes and cytotoxic T cells. The expression of ICAM-1 was decreased in 4/6 CHB patients after interferon-alpha therapy. No relationship between the degree of hepatocyte ICAM-1 expression and viral replication markers (DNA polymerase activity and the presence of HBcA in the liver) was observed in patients with CHB. In addition, no positive correlation was found between the distribution of ICAM-1-positive hepatocytes and HBcAg-positive hepatocytes. These results suggest that ICAM-1 may play an important role in the pathogenesis of hepatocellular injury mediated by cytotoxic T cells in CHB and CHC.
Related Concept Videos
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Hepatitis
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology


